New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations

The development and spread of drug-resistant phenotypes substantially threaten malaria control efforts. Combination therapies have the potential to minimize the risk of resistance development but require intensive preclinical studies to determine optimal combination and dosing regimens. To support t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicha, Sebastian G., Walz, Annabelle, Cherkaoui-Rbati, Mohammed H., Bundgaard, Nils, Kuritz, Karsten, Gumpp, Christin, Gobeau, Nathalie, Möhrle, Jörg, Rottmann, Matthias, Demarta-Gatsi, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664866/
https://www.ncbi.nlm.nih.gov/pubmed/36197116
http://dx.doi.org/10.1128/aac.00556-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664866/
https://www.ncbi.nlm.nih.gov/pubmed/36197116
http://dx.doi.org/10.1128/aac.00556-22

Ejemplares similares